LEADER 01833nam  2200397Ia 450 
001 9910699240603321
005 20230902161635.0
035   $a(CKB)5470000002401501
035   $a(OCoLC)489113506
035   $a(EXLCZ)995470000002401501
100   $a20091215d2009      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aQ4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions$b[electronic resource] $eannex 9, tablet friability general chapter
210  1$a[Rockville, Md?] :$c[U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research]:$c[Center for Biologics Evaluation and Research],$d[2009]
215   $a1 online resource (3 pages)
300   $a"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use"--PDF prelim. p.
300   $a"Current step 2 version 1, dated 11 June 2009"--PDF prelim. p.
320   $aIncludes bibliographical references (pages 2-3).
517   $aQ4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions 
606   $aPharmacopoeias$xStandards$xInternational cooperation
606   $aTablets (Medicine)
615  0$aPharmacopoeias$xStandards$xInternational cooperation.
615  0$aTablets (Medicine)
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 12$aInternational Conference on Harmonisation.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699240603321
996   $aQ4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions$93471792
997   $aUNINA